Role of Saroglitazar in Improving Transient Elastography Parameters in Significant and Advanced Metabolic Dysfunction-Associated Steatohepatitis
Saroglitazar 4 mg daily was associated with significant improvements in liver stiffness, steatosis, transaminases, and lipid parameters over 52 weeks. These findings support its hepatometabolic potential across both early and advanced MASLD/MASH stages in real-world practice.
Authors
- Manish Kak
Institutions
- Institute of Management Technology (IN)
Publication Details
- Journal
- Cureus
- Published
- 2025-12-12
- DOI
- https://doi.org/10.7759/cureus.99044
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00